FI20021626A - Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi - Google Patents
Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi Download PDFInfo
- Publication number
- FI20021626A FI20021626A FI20021626A FI20021626A FI20021626A FI 20021626 A FI20021626 A FI 20021626A FI 20021626 A FI20021626 A FI 20021626A FI 20021626 A FI20021626 A FI 20021626A FI 20021626 A FI20021626 A FI 20021626A
- Authority
- FI
- Finland
- Prior art keywords
- hcv
- hepatitis
- antibodies
- virus
- detection
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title 2
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 238000003018 immunoassay Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 108010067390 Viral Proteins Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72248991A | 1991-06-24 | 1991-06-24 | |
US72248991 | 1991-06-24 | ||
PCT/US1992/005388 WO1993000365A2 (en) | 1991-06-24 | 1992-06-24 | Hepatitis c virus (hcv) polypeptides |
US9205388 | 1992-06-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI20021626A true FI20021626A (fi) | 2002-09-11 |
FI111645B FI111645B (fi) | 2003-08-29 |
Family
ID=24902063
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI935808A FI110099B (fi) | 1991-06-24 | 1993-12-22 | Menetelmä hepatiitti C-viruksen (HCV) polypeptidien valmistamiseksi |
FI20021626A FI111645B (fi) | 1991-06-24 | 2002-09-11 | Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI935808A FI110099B (fi) | 1991-06-24 | 1993-12-22 | Menetelmä hepatiitti C-viruksen (HCV) polypeptidien valmistamiseksi |
Country Status (16)
Country | Link |
---|---|
US (2) | US6346375B1 (fi) |
EP (1) | EP0591431B1 (fi) |
JP (9) | JP3516681B2 (fi) |
KR (1) | KR0185426B1 (fi) |
AT (1) | ATE229543T1 (fi) |
BG (1) | BG61843B1 (fi) |
CA (1) | CA2110058C (fi) |
DE (1) | DE69232871T2 (fi) |
ES (1) | ES2188583T3 (fi) |
FI (2) | FI110099B (fi) |
HU (1) | HU227547B1 (fi) |
NO (1) | NO309528B1 (fi) |
RO (1) | RO117329B1 (fi) |
RU (1) | RU2148587C1 (fi) |
UA (1) | UA40572C2 (fi) |
WO (1) | WO1993000365A2 (fi) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6171782B1 (en) | 1987-11-18 | 2001-01-09 | Chiron Corporation | Antibody compositions to HCV and uses thereof |
US5712088A (en) * | 1987-11-18 | 1998-01-27 | Chiron Corporation | Methods for detecting Hepatitis C virus using polynucleotides specific for same |
US6861212B1 (en) | 1987-11-18 | 2005-03-01 | Chiron Corporation | NANBV diagnostics and vaccines |
US5714596A (en) * | 1987-11-18 | 1998-02-03 | Chiron Corporation | NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus |
US5698390A (en) | 1987-11-18 | 1997-12-16 | Chiron Corporation | Hepatitis C immunoassays |
US6027729A (en) * | 1989-04-20 | 2000-02-22 | Chiron Corporation | NANBV Diagnostics and vaccines |
US5582968A (en) * | 1990-02-16 | 1996-12-10 | United Biomedical, Inc. | Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis |
US5639594A (en) * | 1990-02-16 | 1997-06-17 | United Biomedical, Inc. | Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis |
GB9204274D0 (en) * | 1992-02-28 | 1992-04-08 | Wellcome Found | Novel peptides |
US6667387B1 (en) | 1996-09-30 | 2003-12-23 | N.V. Innogenetics S.A. | HCV core peptides |
US6709828B1 (en) | 1992-03-06 | 2004-03-23 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
DE4240980A1 (de) * | 1992-08-07 | 1994-02-10 | Boehringer Mannheim Gmbh | HCV Peptidantigene und Verfahren zur Bestimmung von HCV |
US7255997B1 (en) | 1993-04-27 | 2007-08-14 | N.V. Innogenetics S.A. | Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
EP0984068B1 (en) | 1993-04-27 | 2012-03-28 | Innogenetics N.V. | Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
PL175360B1 (pl) * | 1993-05-10 | 1998-12-31 | Chiron Corp | Cząsteczka kwasu nukleinowego i kompozycja do wykrywania infekcji wirusa zapalenia wątroby typu C |
ATE249838T1 (de) | 1993-05-12 | 2003-10-15 | Chiron Corp | Konserviertes motiv der hepatitis c virus e2/ns1 region |
US5514539A (en) * | 1993-06-29 | 1996-05-07 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines |
US5639856A (en) | 1993-09-13 | 1997-06-17 | The Regents Of The University Of California | Semaphorin gene family |
AU8003894A (en) * | 1993-10-29 | 1995-05-22 | Srl Inc. | Antigen peptide compound and immunoassay method |
ATE290592T1 (de) * | 1993-11-04 | 2005-03-15 | Innogenetics Nv | Von menschlichen t-zellen immunodominante epitopen des virus der c-hepatitis |
US5709995A (en) * | 1994-03-17 | 1998-01-20 | The Scripps Research Institute | Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
WO1996013590A2 (en) * | 1994-10-21 | 1996-05-09 | Innogenetics N.V. | New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents |
GB2294690B (en) * | 1994-11-01 | 1998-10-28 | United Biomedical Inc | Peptides effective for diagnosis and detection of hepatitis C infection |
US6034064A (en) * | 1995-04-07 | 2000-03-07 | Hoechst Pharmaceuticals & Chemicals K.K. | Peptides and therapeutic agent for autoimmune diseases containing the same |
JPH08333390A (ja) * | 1995-04-07 | 1996-12-17 | Hoechst Japan Ltd | ペプチド及びそれからなる自己免疫疾患治療剤 |
EP0829488A4 (en) * | 1995-04-28 | 1999-04-07 | Srl Inc | ANTIGENIC PEPTIDE COMPOUND AND IMMUNOLOGICAL ASSAY METHOD |
GB9513261D0 (en) * | 1995-06-29 | 1995-09-06 | Smithkline Beecham Biolog | Vaccines |
US6127116A (en) * | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
US6514731B1 (en) | 1996-05-24 | 2003-02-04 | Chiron Corporation | Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens |
ATE311463T1 (de) * | 1996-05-24 | 2005-12-15 | Chiron Corp | Fusionsprotein mit multiplen epitopen |
US7049428B1 (en) | 1998-03-04 | 2006-05-23 | Washington University | HCV variants |
US7338759B1 (en) | 1997-03-04 | 2008-03-04 | Washington University | HCV variants |
ES2316171T3 (es) | 1997-09-22 | 2009-04-01 | Novartis Vaccines And Diagnostics, Inc. | Tampones para estabilizar antigenos hcv. |
ES2310701T3 (es) * | 1998-04-17 | 2009-01-16 | Innogenetics N.V. | Metodos para mejorar la conformacion de proteinas por medio de agentes reductores. |
US7052830B1 (en) * | 1998-06-09 | 2006-05-30 | Branch Andrea D | Hepatitis C virus peptides and uses thereof |
US7052696B2 (en) * | 1998-07-10 | 2006-05-30 | The United States Of America As Represented By The Department Of Health And Human Services | Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins |
US6191256B1 (en) * | 1998-11-20 | 2001-02-20 | Bayer Corporation | Recombinant factor VIII binding peptides |
CA2377525A1 (en) * | 1999-07-19 | 2001-03-29 | Epimmune, Inc. | Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
US20070031446A1 (en) | 2003-07-11 | 2007-02-08 | Intercell Ag | Hcv vaccines |
US6630298B2 (en) | 2000-06-15 | 2003-10-07 | Chiron Corporation | HCV antigen/antibody combination assay |
KR100801123B1 (ko) | 2000-08-17 | 2008-02-05 | 트리펩 아베 | 리바비린 함유 백신 및 이것의 사용 방법 |
US6858590B2 (en) * | 2000-08-17 | 2005-02-22 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
US7022830B2 (en) * | 2000-08-17 | 2006-04-04 | Tripep Ab | Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
US6680059B2 (en) * | 2000-08-29 | 2004-01-20 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
EP1195381A1 (de) * | 2000-09-28 | 2002-04-10 | Immusystems GmbH | CD4+ T-Lymphozyten spezifische Hepatitis C Virus-Epitope |
MXPA03009632A (es) | 2001-04-24 | 2004-06-30 | Innogenetics Nv | Proteinas de la envoltura de vhc glucosiladas en la estructura central. |
US20030152942A1 (en) * | 2001-05-09 | 2003-08-14 | Lance Fors | Nucleic acid detection in pooled samples |
US7196183B2 (en) | 2001-08-31 | 2007-03-27 | Innogenetics N.V. | Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent |
US20030100467A1 (en) * | 2001-09-12 | 2003-05-29 | Wolfgang Aehle | Binding phenol oxidizing enzyme-peptide complexes |
AR045702A1 (es) | 2001-10-03 | 2005-11-09 | Chiron Corp | Composiciones de adyuvantes. |
US7332269B2 (en) * | 2001-11-11 | 2008-02-19 | Ortho-Clinical Diagnostics, Inc. | HCV core protein sequences |
WO2003073097A2 (en) * | 2002-02-28 | 2003-09-04 | Intercell Ag | Methods for isolating ligands e.g. t cell epitopes |
AU2003218111B8 (en) * | 2002-03-11 | 2008-11-20 | Lab 21 Limited | Methods and compositions for identifying and characterizing hepatitis C |
AU2003301865A1 (en) * | 2002-05-16 | 2004-06-07 | The General Hospital Corporation | Epitopes of hepatitis c virus |
FR2839722A1 (fr) | 2002-05-17 | 2003-11-21 | Bio Merieux | Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c |
CA2484941A1 (en) | 2002-07-24 | 2004-02-05 | Intercell Ag | Antigens encoded by alternative reading frame from pathogenic viruses |
ES2312806T3 (es) | 2002-09-09 | 2009-03-01 | Novartis Vaccines And Diagnostics, Inc. | Ensayo de vhc. |
US7378234B2 (en) | 2002-09-13 | 2008-05-27 | Intercell Ag | Method for isolating hepatitis C virus peptides |
EP2287311A1 (en) * | 2003-03-04 | 2011-02-23 | Intercell AG | Streptococcus pyogenes antigens |
AU2004224746B2 (en) | 2003-03-24 | 2009-04-23 | Valneva Austria Gmbh | Improved vaccines |
WO2004084937A1 (en) * | 2003-03-24 | 2004-10-07 | Intercell Ag | Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses |
EP2311991A1 (en) | 2003-04-15 | 2011-04-20 | Intercell AG | S. pneumoniae antigens |
US7731967B2 (en) | 2003-04-30 | 2010-06-08 | Novartis Vaccines And Diagnostics, Inc. | Compositions for inducing immune responses |
WO2005010035A2 (en) * | 2003-07-22 | 2005-02-03 | Branch Andrea D | Alternate reading frame polypeptides derived from hepatitis c and methods of their use |
ES2596753T3 (es) | 2003-08-29 | 2017-01-11 | Fujirebio Europe N.V. | Nuevo clado del virus de la hepatitis C y secuencias prototipo del mismo |
FR2859909B1 (fr) | 2003-09-22 | 2007-09-07 | Biomerieux Sa | Procede de preparation de microparticules bioresorbables, microparticules obtenues et utilisation |
CA2558963A1 (en) * | 2004-04-16 | 2005-12-15 | Genentech, Inc. | Omi pdz modulators |
EP1802778B1 (en) * | 2004-08-27 | 2011-10-05 | Novartis Vaccines and Diagnostics, Inc. | Hcv multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof |
JP4897792B2 (ja) | 2005-04-20 | 2012-03-14 | ビロメッド カンパニー, リミテッド | 融合タンパク質の分離のための組成物および方法 |
US7968697B2 (en) * | 2005-05-25 | 2011-06-28 | Chrontech Pharma Ab | Hepatitis C virus non-structural NS3/4A fusion gene |
CA2661492A1 (en) | 2006-08-25 | 2008-02-28 | Novartis Ag | Hcv fusion polypeptides |
JP4975600B2 (ja) * | 2007-03-16 | 2012-07-11 | シスメックス株式会社 | Hcv抗体測定用試薬キット及びhcv抗体測定方法 |
US8071561B2 (en) | 2007-08-16 | 2011-12-06 | Chrontech Pharma Ab | Immunogen platform |
US20090214593A1 (en) * | 2007-08-16 | 2009-08-27 | Tripep Ab | Immunogen platform |
US8815253B2 (en) | 2007-12-07 | 2014-08-26 | Novartis Ag | Compositions for inducing immune responses |
US20100104555A1 (en) * | 2008-10-24 | 2010-04-29 | The Scripps Research Institute | HCV neutralizing epitopes |
US9636410B2 (en) | 2011-07-06 | 2017-05-02 | Glaxosmithkline Biologicals Sa | Cationic oil-in-water emulsions |
US9655845B2 (en) | 2011-07-06 | 2017-05-23 | Glaxosmithkline Biologicals, S.A. | Oil-in-water emulsions that contain nucleic acids |
FR2984328B1 (fr) | 2011-12-20 | 2016-12-30 | Bio-Rad Innovations | Procede de detection d'une infection par le virus de l'hepatite c |
WO2013150450A1 (en) * | 2012-04-02 | 2013-10-10 | Universidade Do Porto | Hcv homolog fragments, cell-lines and applications thereof |
EP3564384A1 (en) | 2013-03-14 | 2019-11-06 | Abbott Laboratories | Hcv core lipid binding domain monoclonal antibodies |
CN105228649B (zh) | 2013-03-14 | 2019-01-18 | 雅培制药有限公司 | Hcv抗原-抗体组合测定和方法以及用在其中的组合物 |
EP2970947A4 (en) | 2013-03-14 | 2016-10-12 | Abbott Lab | RECOMBINANT HCV NS3 ANTIGENS AND THEIR MUTANTS FOR ENHANCED ANTIBODY DETECTION |
ES2832335T3 (es) | 2015-03-27 | 2021-06-10 | Ortho Clinical Diagnostics Inc | Polipéptidos NS4A/NS3 modificado del VHC y usos de los mismos |
CN111153963B (zh) * | 2020-01-19 | 2021-08-10 | 华南理工大学 | 抗炎五肽及其提取分离方法和在改善记忆中的应用 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4861588A (en) * | 1985-02-05 | 1989-08-29 | New York Blood Center, Inc. | Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
DE3886363T3 (de) * | 1987-11-18 | 2004-09-09 | Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville | NANBV-Diagnostika |
US5350671A (en) * | 1987-11-18 | 1994-09-27 | Chiron Corporation | HCV immunoassays employing C domain antigens |
GB2212511B (en) | 1987-11-18 | 1992-01-22 | Chiron Corp | Hepatitis c virus |
AU650038B2 (en) | 1988-03-11 | 1994-06-09 | Abbott Laboratories | CKS method of protein synthesis |
US5312737A (en) | 1988-03-11 | 1994-05-17 | Abbott Laboratories | CKS method of HCV protein synthesis |
WO1990011089A1 (en) * | 1989-03-17 | 1990-10-04 | Chiron Corporation | Nanbv diagnostics and vaccines |
EP0416725A3 (en) | 1989-07-14 | 1991-03-20 | Chugai Seiyaku Kabushiki Kaisha | Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production |
JP2818761B2 (ja) | 1989-09-14 | 1998-10-30 | 財団法人化学及血清療法研究所 | 非a非b型肝炎ウイルス抗原をコードする核酸断片およびその利用法 |
US5372928A (en) | 1989-09-15 | 1994-12-13 | Chiron Corporation | Hepatitis C virus isolates |
CA2065287C (en) * | 1989-09-15 | 1999-12-21 | Tatsuo Miyamura | New hcv isolates |
LU87861A1 (fr) * | 1989-12-18 | 1991-10-08 | Wellcome Found | Agent viral |
JPH03190898A (ja) | 1989-12-21 | 1991-08-20 | Shima Kenkyusho:Kk | 合成ポリペプチド及びそれを用いたhcv抗体測定試薬 |
CA2032907C (en) * | 1989-12-22 | 2002-05-14 | Richard R. Lesniewski | Hepatitis c assay |
EP0435229A1 (en) | 1989-12-27 | 1991-07-03 | Sanwa Kagaku Kenkyusho Co., Ltd. | DNA of non-A, non-B hepatitis virus gene, its clone and use thereof |
KR940000755B1 (ko) * | 1990-02-16 | 1994-01-29 | 유나이티드 바이오메디칼 인코오포레이티드 | Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드 |
US5106726A (en) * | 1990-02-16 | 1992-04-21 | United Biomedical, Inc. | Synthetic peptides specific for the detection of antibodies to HCV |
EP0527788B1 (en) | 1990-04-04 | 2004-06-30 | Chiron Corporation | Hepatitis c virus protease |
ES2152922T3 (es) * | 1990-04-06 | 2001-02-16 | Genelabs Tech Inc | Epitopos del virus de la hepatitis c. |
JPH044880A (ja) | 1990-04-20 | 1992-01-09 | Terumasa Arima | 非a非b型肝炎抗原をコードするdna及びポリペプチド |
JP3268502B2 (ja) | 1990-06-12 | 2002-03-25 | 徹雄 中村 | 非a非b型肝炎ウイルス関連ポリヌクレオチド、ポリペプ タイド |
JPH0446196A (ja) | 1990-06-13 | 1992-02-17 | Kuraray Co Ltd | 抗原蛋白質およびそれをコードしているdna断片 |
AU652941B2 (en) | 1990-06-25 | 1994-09-15 | Research Foundation For Microbial Diseases Of Osaka University, The | Non-A, Non-B hepatitis virus particles |
EP0933426A1 (en) | 1990-06-25 | 1999-08-04 | The Research Foundation for Microbial Diseases of Osaka University | Non-a, non-b hepatitis virus genomic cdna fragments and antigen polypeptides |
EP0468657A3 (en) | 1990-07-09 | 1992-02-05 | Tonen Corporation | Non-a non b hepatitis-specific antigen and its use in hepatitus diagnosis |
JPH04126086A (ja) | 1990-07-12 | 1992-04-27 | Yamanouchi Pharmaceut Co Ltd | 非a非b型肝炎ウイルス抗原ポリペプチド、該抗原ポリペプチドをコードするポリヌクレオチド、及びそれらを用いた非a非b型肝炎の診断法 |
CA2047792C (en) | 1990-07-26 | 2002-07-02 | Chang Y. Wang | Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines |
CZ282573B6 (cs) | 1990-08-10 | 1997-08-13 | Chiron Corporation | Způsob detekce HCV sekvence, souprava a reakční činidlo pro detekci HCV |
CA2049679C (en) | 1990-08-24 | 2005-06-21 | Sushil G. Devare | Hepatitis c assay utilizing recombinant antigens |
CA2090335A1 (en) | 1990-08-25 | 1992-02-26 | Suzanne Zebedee | Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |
JP3055793B2 (ja) | 1990-09-07 | 2000-06-26 | 財団法人化学及血清療法研究所 | 非a非b型肝炎ウイルス融合ペプチドおよびその製法 |
JPH04144686A (ja) | 1990-10-04 | 1992-05-19 | Kunitada Shimotoono | 構造蛋白質遺伝子、組換えベクター、それにより形質転換された大腸菌、ポリペプチドおよびポリペプチドの製造方法 |
JPH04159298A (ja) | 1990-10-19 | 1992-06-02 | Olympus Optical Co Ltd | Hcvペプチド |
DE59109221D1 (de) | 1990-11-03 | 2001-11-15 | Dade Behring Marburg Gmbh | HCV-spezifische Peptide, Mittel dazu und ihre Verwendung |
EP0485209A1 (en) | 1990-11-08 | 1992-05-13 | Immuno Japan Inc. | Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides |
JPH04179482A (ja) | 1990-11-11 | 1992-06-26 | Kunitada Shimotoono | C型肝炎ウイルス由来の遺伝子 |
JPH04187090A (ja) | 1990-11-22 | 1992-07-03 | Toshio Shikata | 非a非b型肝炎抗原をコードするdna及びポリペプチド |
WO1992009634A1 (en) | 1990-11-29 | 1992-06-11 | Toray Industries, Incorporated | Non-a non-b hepatitis virus antigen protein |
DE69029092T2 (de) * | 1990-12-14 | 1997-04-17 | Innogenetics N.V., Gent | Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus |
KR930703361A (ko) | 1991-01-31 | 1993-11-29 | 찰스 엠. 브룩 | 추정의 c형 간염 바이러스(hcv) 외막 영역에 대한 모노클로날 항체 및 이의 사용 방법 |
JP3244284B2 (ja) | 1991-02-14 | 2002-01-07 | 武田薬品工業株式会社 | C型肝炎ウイルス関連抗体および抗原の測定法 |
US5574132A (en) | 1991-04-05 | 1996-11-12 | Biochem Immunosystems Inc. | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) |
JPH0568562A (ja) | 1991-05-30 | 1993-03-23 | Sanwa Kagaku Kenkyusho Co Ltd | ヒトC型肝炎ウイルスのcDNA、そのクローン及びこれらの利用法 |
JP3055964B2 (ja) | 1991-05-31 | 2000-06-26 | 株式会社トクヤマ | Hcv 抗原活性ポリペプチド、ポリペプチドの製造方法、形質転換された大腸菌、および抗hcv 抗体の検出方法 |
FR2677372B1 (fr) | 1991-06-06 | 1994-11-10 | Pasteur Institut | Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques. |
BR9206131A (pt) | 1991-06-10 | 1995-05-02 | Lucky Ltd | Hepatite C: diagnóstico e vacinas |
CA2070952A1 (en) | 1991-06-11 | 1992-12-12 | Makoto Seki | Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same |
AU648912B2 (en) | 1991-06-13 | 1994-05-05 | Dade International Inc. | Immunoassay for non-A non-B hepatitis |
JP3103180B2 (ja) | 1992-01-30 | 2000-10-23 | 昭和電工株式会社 | 軟質性合成樹脂製シート |
JP3190898B2 (ja) | 1998-11-09 | 2001-07-23 | 米沢日本電気株式会社 | ノート型パーソナルコンピュータ |
-
1992
- 1992-06-24 RU RU93058563A patent/RU2148587C1/ru active
- 1992-06-24 JP JP50167193A patent/JP3516681B2/ja not_active Expired - Lifetime
- 1992-06-24 CA CA002110058A patent/CA2110058C/en not_active Expired - Lifetime
- 1992-06-24 ES ES92914835T patent/ES2188583T3/es not_active Expired - Lifetime
- 1992-06-24 HU HU9303703A patent/HU227547B1/hu unknown
- 1992-06-24 KR KR1019930704022A patent/KR0185426B1/ko not_active IP Right Cessation
- 1992-06-24 WO PCT/US1992/005388 patent/WO1993000365A2/en active IP Right Grant
- 1992-06-24 DE DE69232871T patent/DE69232871T2/de not_active Expired - Lifetime
- 1992-06-24 UA UA93004481A patent/UA40572C2/uk unknown
- 1992-06-24 EP EP92914835A patent/EP0591431B1/en not_active Expired - Lifetime
- 1992-06-24 RO RO93-01778A patent/RO117329B1/ro unknown
- 1992-06-24 AT AT92914835T patent/ATE229543T1/de active
-
1993
- 1993-12-10 NO NO934542A patent/NO309528B1/no not_active IP Right Cessation
- 1993-12-22 FI FI935808A patent/FI110099B/fi not_active IP Right Cessation
- 1993-12-23 BG BG98332A patent/BG61843B1/bg unknown
-
1995
- 1995-03-14 US US08/403,590 patent/US6346375B1/en not_active Expired - Lifetime
- 1995-05-18 US US08/444,818 patent/US6150087A/en not_active Expired - Lifetime
-
1999
- 1999-11-25 JP JP33516799A patent/JP3514680B2/ja not_active Expired - Lifetime
-
2002
- 2002-09-11 FI FI20021626A patent/FI111645B/fi not_active IP Right Cessation
-
2003
- 2003-02-28 JP JP2003054819A patent/JP3514751B2/ja not_active Expired - Lifetime
- 2003-11-14 JP JP2003385979A patent/JP3619827B2/ja not_active Expired - Lifetime
-
2004
- 2004-09-27 JP JP2004280446A patent/JP3926817B2/ja not_active Expired - Lifetime
-
2006
- 2006-11-21 JP JP2006314881A patent/JP4456596B2/ja not_active Expired - Lifetime
- 2006-11-21 JP JP2006314880A patent/JP4456595B2/ja not_active Expired - Lifetime
-
2007
- 2007-08-21 JP JP2007215324A patent/JP2008001716A/ja not_active Withdrawn
-
2008
- 2008-10-20 JP JP2008270386A patent/JP2009084285A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI20021626A (fi) | Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi | |
NO870412L (no) | Peptider. | |
UA39944C2 (uk) | Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі | |
DK0644202T3 (da) | Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus | |
DE69131707D1 (de) | Nachweis von Hepatits C mit Verwendung rekombinanter Antigene | |
DE69230917D1 (de) | Verfahren zur detektion von hepatitis c | |
DE3579856D1 (de) | Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern. | |
CA2116026A1 (en) | Hepatitis c assay utilizing recombinant antigens to c-100 region | |
SG145521A1 (en) | Synthetic antigens for the detection of antibodies to hepatitis c virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer of assignment of patent |
Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC. Free format text: NOVARTIS VACCINES AND DIAGNOSTICS, INC. |
|
MA | Patent expired |